Moderna Ramps Up Vaccine Manufacturing in U.S. and Europe

Posted by ISPE Boston
On May 5, 2021

Moderna is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which it expects will increase global 2022 capacity to up to 3 billion doses of its COVID-19 vaccine. The company will use its cash balance to fund these investments. These investments allow for a doubling of drug substance manufacturing […]

Affinia Therapeutics Closes $110 Million Financing Round

Posted by ISPE Boston
On May 5, 2021

Gene therapy company Affinia Therapeutics has closed a $110 million Series B financing. Affinia Therapeutics will use the proceeds to further develop its proprietary gene therapy platform, advance programs into the clinic, and for general corporate purposes. “Since founding the company, we have had the interest of leading biotech investors as well as strategic partners […]

Win Big with ISPE Boston on LinkedIn

Posted by ISPE Boston
On May 5, 2021

How about something shiny and new to help you get through the winter doldrums? One lucky ISPE Boston follower on LinkedIn will be selected to win their choice of the following prizes: An Oculus Quest 2 Advanced All-in-One Virtual Reality Headset A Solo Stove Smokeless Stainless Steel 19.5” outdoor firepit A $300 gift card to […]

Chapter Member Anniversaries: May 2021

Posted by ISPE Boston
On May 4, 2021

Please congratulate the following members celebrating milestone anniversaries in May 2021. Their dedication to ISPE, the Boston Area Chapter and the industry is applauded! Over Twenty Years Karen Conte, Pfizer Timothy W. Crowley, Sentrol, Inc. Daniel M. Duffy, Jr., Sanofi John H. Evers, MS, Lantheus Medical Imaging Sherry L. Flaherty, Amgen Inc Joshua Froimson, AbbVie […]

Welcome New Members April 2021!

Posted by ISPE Boston
On May 4, 2021

We would like to introduce the Members who joined ISPE in April 2021, welcome them to the Chapter and encourage them (and all of our members) to take advantage of the many professional development, networking and information resources available through ISPE. Fellow ISPE members are a terrific resource for help with everyday professional challenges. And […]

“Pharma Plant War Stories” Spring Conference Delivers

Posted by Howard Sneider
On April 29, 2021

The Boston Area Chapter held their Virtual Spring Conference, Pharma Plant War Stories: Lessons Learned & Best Practices from Design to Operation, over the week of April 19-23. This virtual event was comprised of three tracks—Automation, CQV, and Design—and attendees had access to on-demand educational webinar sessions to watch on their own schedules. During the […]

ISPE Scholarship Application Period Opens on May 3

Posted by ISPE Boston
On April 28, 2021

Are you interested in pursuing a career in biotechnology and pharmaceutical manufacturing? Are you an undergrad or grad student enrolled in an accredited college or university located in New England or the Albany/Schenectady area? Are you pursuing a certification or an associate, bachelor, master or a doctoral degree in any of the STEM disciplines? Do […]

We Need Your Input!

Posted by ISPE Boston
On April 28, 2021

And you have two chances to provide it! First, the Chapter’s Educational Program Committee (EPC) has launched their Annual Member Survey. The survey helps the committee measure interest in potential topics for upcoming educational programs. Please take a few minutes to complete the survey and let the EPC know your preferences. As an added incentive, […]

Vertex Ups Stake in CRISPR Therapeutics by $900M

Posted by ISPE Boston
On April 22, 2021

Vertex Pharmaceuticals and CRISPR Therapeutics have amended their collaboration agreement to develop, manufacture and commercialize CTX001, an investigational CRISPR/Cas9-based gene editing therapy that is being developed as a potentially curative therapy for sickle cell disease (SCD) and transfusion-dependent beta-thalassemia (TDT). CTX001 represents the first potential treatment to emerge from the joint research program initiated in […]

Adagio Raises $336M for COVID-19 Treatment

Posted by ISPE Boston
On April 22, 2021

Adagio Therapeutics has completed a $336 million Series C financing that will support continued advancement of ADG20, Adagio’s lead clinical candidate being developed as a single agent for both the treatment and prevention of COVID-19, as well as potential future coronaviruses. ADG20 is a monoclonal antibody distinguished from other antibody treatments targeting the COVID-19 by […]

Page 48 of 117«‹46 474849 50 ›»